Evidence map›Paper›PMID 25511777›Full record

Trial reportBMC oral health2014

Antimicrobial photodynamic therapy suppresses dental plaque formation in healthy adults: a randomized controlled clinical trial.

Akiko Ichinose-Tsuno, Akira Aoki, Yasuo Takeuchi, Teruo Kirikae, Takuro Shimbo, Masaichi-Chang-Il Lee, Fumihiko Yoshino, Yutaka Maruoka, Toshiyuki Itoh, Isao Ishikawa and 1 more

Open access · goldAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in BMC oral health, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. The Efficacy of Photodynamic Therapy againstActa medica Philippina · 2025
    Article
  6. Article
  7. Review
  8. Review
  9. Nanotechnology for Dentistry: Prospects and Applications.Nanomaterials (Basel, Switzerland) · 2023
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Anti-Oral Pathogens ofMedicina (Kaunas, Lithuania) · 2019
    Article
  19. Article
  20. Antimicrobial photodynamic activity and cytocompatibility of AuInternational journal of nanomedicine · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Akiko Ichinose-Tsuno
Akira AokiDepartment of Periodontology, Graduate school of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-Ku, Tokyo 113-8549, Japan. aoperi@tmd.ac.jp.
Yasuo Takeuchi
Teruo Kirikae
Takuro Shimbo
Masaichi-Chang-Il Lee
Fumihiko Yoshino
Yutaka Maruoka
Toshiyuki Itoh
Isao Ishikawa
Yuichi Izumi
Tokyo Medical and Dental University · JPNational Center for Global Health and Medicine · JPKanagawa Dental University · JPOhta Nishinouchi Hospital · JPTokyo Women's Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOral care is important for oral and systemic health, especially for elderly institutionalized individuals and compromised patients. However, conventional mechanical plaque control is often difficult for these patients because of the pain or the risk of aspiration. Although antimicrobial photodynamic therapy (aPDT), which is considered an alternative or adjunct to mechanical approaches, has potential application as a less stressful method of daily plaque control, no clinical application of this technique has been reported.

methodsWe investigated the inhibitory effect of a combination of toluidine blue O (TBO), and a red light-emitting diode (LED) on dental plaque formation in healthy volunteers. The optimal concentration of TBO was determined in preliminary in vitro experiments to evaluate the bactericidal effect of aPDT on Streptococcus oralis and to clarify its safety in fibroblast cells. To survey the mechanism of TBO-mediated aPDT, the quality and quantity of reactive oxygen species (ROS) generated during aPDT were also examined using electron spin resonance (ESR) spectroscopy. Subsequently, the inhibitory effect of aPDT on dental plaque formation was investigated in eleven subjects as a clinical pilot study. The right or left mandibular premolars were randomly assigned to the treatment (with aPDT) or control (without aPDT) groups. In total, aPDT was applied six times (twice per day) to the teeth in the test group over a period of four days. On the fourth day, the study concluded and the analyses were performed.

resultsA combination of 500 or 1000 μg/ml TBO and LED irradiation for 20 s significantly decreased the number of colony forming units of Streptococcus oralis. The cytotoxicity of aPDT was comparable to that of standard antiseptics used in the oral cavity. Hydroxyl radicals were detected by ESR analysis, but singlet oxygen was not. A randomized controlled trial demonstrated that aPDT with 1000 μg/ml TBO and red LED irradiation significantly suppressed dental plaque formation without harming teeth or the surrounding tissues.

conclusionsaPDT has the potential to be a promising novel technical modality for dental plaque control.

trial registrationThis trial was registered with University Hospital Medical Information Network Clinical Trials Registry (number UMIN000012504).

Indexed as

AdultAnimalsAnti-Bacterial AgentsAnti-Infective Agents, LocalBacterial LoadCell LineCell SurvivalColorimetryDental PlaqueElectron Spin Resonance SpectroscopyFibroblastsHumansHydroxyl RadicalMaterials TestingMicePhotochemotherapyAnti-Bacterial AgentsAnti-Infective Agents, LocalHydroxyl RadicalPhotosensitizing AgentsReactive Oxygen SpeciesTolonium Chloride

Identifiers

PMID25511777
PMCPMC4289549
OpenAlexW1594623680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.